Edge Pharma has signed an agreement with ANI Pharmaceuticals to market the company’s FDA approved Vancomycin Hydrochloride for Oral Solution USP, a generic equivalent to Vancocin. The specific focus will be the hospital outpatient pharmacy market.   ANI is a leading provider of Vancomycin Hydrochloride to retail pharmacies and long-term care facilities, as well as the manufacturer of over 40 other brand name and generic medications.   Vancomycin Hydrochloride for Oral Solution is a prescri...